This FTSE 100 stock has grown for 8 years – would I buy now?

I think the size and reputation of Rentokil Initial plc (LON:RTO) mean this FTSE 100 (INDEXFTSE: UKX) stock can continue to gain market share, but is that enough to make me buy?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With the focus on pest control and hygiene, I believe there’s plenty of scope for the Rentokil Initial (LSE:RTO) business to grow. The question is, would I buy? Let’s look at the investment case.

On the plus side, the world is becoming more hygiene-conscious, not only the West, but also emerging markets, and pest problems (from moths to mice to bed bugs) are also growing.

When I first started researching this company, I noticed its share price has been on an upward trajectory for the past eight years and felt encouraged that this reflects the market potential and powerful reputation of the brand.

Rentokil Initial’s customer base is as varied as it is large. From the individual who wants rid of a flea infestation to the hotel eradicating bed bugs, plus hospitals, prisons and restaurants. You name it, Rentokil has it covered.

Along with the pest control ops, the Initial business supplies hygiene solutions, workwear, personal protective equipment and specialist cleaning to the pharmaceutical and healthcare sectors. You may have seen its No-touch washroom accessories appearing in public areas in recent years. Initial is heavily investing in this technology, complementing its hygiene strategies.

So far so good and having dug a little deeper into its operations, I expect continued growth. However, I have also come across some red flags, which make me wary of how this FTSE 100 stock will perform.

Acquisitions and legal wrangles

After the successful acquisition of 42 smaller pest control businesses in 2018, the Competition and Markets Authority (CMA) challenged Rentokil Initial over its acquisition of Cannon Hygiene. The CMA found that the merger would reduce the choice of suppliers available to customers of washroom waste removal and ordered Rentokil to sell the contracts that Cannon had brought in before the merger.

In February’s final results, the firm said these contracts represent a small part of the acquired business.  I imagine this will reduce the acquisition-linked revenue, but it’s unclear by how much.

Now the CMA is again investigating the company over its completed acquisition of MPCL (formerly Mitie Pest Control Limited). This issue is ongoing. But in 2019’s first quarter, growth continued as the company continued its M&A mission, signing four deals in Pest Control and four in Hygiene.

Misconstrued financials

Rentokil Initial’s market cap is £7.3bn. Earnings-per-share (EPS) was negative in 2018 at -5.3p, compared with 37.21p in 2017. This negative EPS has likely affected the price-to-earnings-to-growth ratio (PEG), which is a very high 3.7, suggesting weaker long-term growth prospects. 

But the EPS plunge was due to asset disposals in 2017, amounting to a one-off profit of £449m. Then in 2018, it was subject to a pension settlement charge of £341.6m. This was one of the largest moves ever undertaken in the UK, eradicating pension liabilities from the balance sheet on completion (expected 2020) so future investments can focus on delivering profitable growth.

2018 dividends rose 15% to 4.47p from 3.88p the year before and the dividend cover was almost 3, so cash flow covers this easily. The dividend yield of 1.11% seems low, but it’s better than the nothing that I’d get from some sector peers.

Although there are concerns Rentokil Initial may be overvalued and I don’t advocate ignoring the ongoing legal challenges, I see many reasons for this company continue to thrive. So would I buy? Maybe I’ll wait and buy on a dip.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kirsteen has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

How much would I need to invest in income shares to earn £300 a month?

What kind of lump sum would be required to earn £300 a month by taking advantage of some of the…

Read more »

Investing For Beginners

Up 31% in a month, could this FTSE 250 stock be getting bought out?

Jon Smith takes a look at speculation that's pushing the share price of a FTSE 250 share higher and considers…

Read more »

Investing Articles

Here’s how I’d follow Warren Buffett to start building passive income in 2025

Ben McPoland highlights one FTSE 250 firm with a strong competitive edge that he thinks can continue rewarding investors with…

Read more »

Investing Articles

Burberry shares: undervalued FTSE gems that are ready to rocket?

Burberry shares soared at the beginning of the week as the takeover rumour mill went into overdrive. Is Paul Summers…

Read more »

US Stock

Here are the latest share price forecasts for S&P 500 giant Amazon

Amazon has generated monster gains for investors over the last decade. And Wall Street analysts believe the S&P 500 stock…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

2 high-yield FTSE 250 shares I’d buy today — and 1 that I’d avoid

UK markets have felt some volatility after last week’s Budget and the FTSE 250 was no stranger to it. Our…

Read more »

Investing Articles

3 reasons the Rolls-Royce share price could soar over the next decade

Sustainable aviation fuel, narrow-body aircraft, and small nuclear reactors could all keep the Rolls-Royce share price climbing over the next…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

Here’s how much income I’d get if I invested my entire £20k ISA in cheap BT shares

BT shares are on the up but still cheap, while the FTSE 100 telecoms stock offers a good yield too.…

Read more »